Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$334M |
| 2 |
Marathon Petroleum
MPC
|
+$283M |
| 3 |
CVS Health
CVS
|
+$227M |
| 4 |
ConocoPhillips
COP
|
+$172M |
| 5 |
Linde
LIN
|
+$128M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$740M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$612M |
| 3 |
ANDV
Andeavor
ANDV
|
+$447M |
| 4 |
Cisco
CSCO
|
+$307M |
| 5 |
CA
CA, Inc.
CA
|
+$252M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Industrials | 13.02% |
| 3 | Technology | 12.73% |
| 4 | Healthcare | 10.57% |
| 5 | Consumer Discretionary | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Syndax Pharmaceuticals
SNDX
$1.69B
| $3.6M | ﹤0.01% |
810,184
+14,417
| +2% | +$79K |
|
2702
eGain
EGAN
$187M
| $3.59M | ﹤0.01% |
546,940
+72,341
| +15% | +$526K |
|
2703
Angi Inc
ANGI
$229M
| $3.56M | ﹤0.01% |
22,179
+644
| +3% | +$117K |
|
2704
Intellia Therapeutics
NTLA
$1.49B
| $3.55M | ﹤0.01% |
260,259
+217,071
| +503% | +$4.03M |
|
2705
Nomura Holdings
NMR
$28.3B
| $3.55M | ﹤0.01% |
953,938
-60,716
| -6% | -$272K |
|
|
SBBX
2706
DELISTED
SB One Bancorp Common Stock
SBBX
| $3.53M | ﹤0.01% |
172,749
+29,846
| +21% | +$697K |
|
|
CYOU
2707
DELISTED
Changyou.com Limited American Depositary Share
CYOU
| $3.53M | ﹤0.01% |
192,900
+23,779
| +14% | +$394K |
|
2708
Liberty Global Class A
LBTYA
$3.62B
| $3.53M | ﹤0.01% |
165,222
-225
| -0.1% | -$5.52K |
|
|
PFSW
2709
DELISTED
PFSweb, Inc.
PFSW
| $3.52M | ﹤0.01% |
687,076
+2,960
| +0.4% | +$19K |
|
|
RAD
2710
DELISTED
Rite Aid Corporation
RAD
| $3.48M | ﹤0.01% |
245,668
-59,362
| -19% | -$1.25M |
|
2711
Destination XL Group
DXLG
$31.2M
| $3.47M | ﹤0.01% |
1,600,863
+13,100
| +0.8% | +$35K |
|
2712
Teekay Tankers
TNK
$2.75B
| $3.47M | ﹤0.01% |
466,996
-17,289
| -4% | -$148K |
|
2713
BGSF Inc
BGSF
$59.5M
| $3.45M | ﹤0.01% |
166,964
+11,303
| +7% | +$270K |
|
|
EPZM
2714
DELISTED
Epizyme, Inc
EPZM
| $3.43M | ﹤0.01% |
556,341
+317,157
| +133% | +$2.42M |
|
2715
Flotek Industries
FTK
$852M
| $3.43M | ﹤0.01% |
523,825
-15,794
| -3% | -$160K |
|
|
EVRI
2716
DELISTED
Everi Holdings
EVRI
| $3.41M | ﹤0.01% |
662,127
-4,600
| -0.7% | -$31.4K |
|
|
HLG
2717
DELISTED
Hailiang Education Group Inc. American Depositary Shares
HLG
| $3.41M | ﹤0.01% |
68,166
+745
| +1% | +$44.5K |
|
2718
RGC Resources
RGCO
$223M
| $3.38M | ﹤0.01% |
112,821
+2,577
| +2% | +$71.6K |
|
|
HFBC
2719
DELISTED
HopFed Bancorp Inc
HFBC
| $3.34M | ﹤0.01% |
251,188
+8,751
| +4% | +$135K |
|
2720
Protagonist Therapeutics
PTGX
$8.79B
| $3.3M | ﹤0.01% |
490,267
+122,250
| +33% | +$970K |
|
|
BRG
2721
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $3.29M | ﹤0.01% |
364,439
+9,714
| +3% | +$89.7K |
|
2722
iShares MSCI EAFE Value ETF
EFV
$28.8B
| $3.27M | ﹤0.01% |
+72,419
| New | +$3.49M |
|
2723
ACNB Corp
ACNB
$656M
| $3.27M | ﹤0.01% |
83,354
+8,628
| +12% | +$326K |
|
|
FTD
2724
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $3.24M | ﹤0.01% |
2,188,373
-23,752
| -1% | -$50.5K |
|
2725
Biglari Holdings Class A
BH.A
$1.25B
| $3.23M | ﹤0.01% |
5,504
+526
| +11% | +$407K |
|
Similar funds
Dimensional Fund Advisors's Q4 2018 Portfolio in Review
As of Q4 2018, Dimensional Fund Advisors held 3,519 positions worth $221B, down 16% from $263B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 4.6%. Dimensional Fund Advisors opened 94 new positions and exited 67, leaving the 3,519-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.
- Dimensional Fund Advisors's largest Q4 2018 buy was Linde: 812,164 shares worth $127M.
- Dimensional Fund Advisors added most to Cigna in Q4 2018, an estimated $334M increase.
- Dimensional Fund Advisors's biggest Q4 2018 reduction was Cisco, cutting an estimated $307M.
- Dimensional Fund Advisors fully exited Aetna Inc in Q4 2018, selling an estimated $740M.
- Dimensional Fund Advisors's ten largest holdings make up 9.7% of its $221B portfolio in Q4 2018.
- Dimensional Fund Advisors opened 94 new positions and closed 67 in Q4 2018.
- Dimensional Fund Advisors's portfolio value fell 16% quarter-over-quarter to $221B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.